Mitsubishi Tanabe Pharma's CSR
The Mitsubishi Tanabe Pharma Group's corporate philosophy — We contribute to the healthier lives of people around the world through the creation of pharmaceuticals — reflects universal values, and the realization of that philosophy is our social mission. The topic of corporate social responsibility is a focus of attention, and in this setting the Company needs to maintain an appropriate understanding of the changing state of affairs in society and to actively contribute to the resolution of social issues. In addition, there is a growing commitment around the world to working toward the resolution of environmental and social issues through worldwide initiatives, such as the SDGs adopted at a United Nations summit held in 2015. In this setting, companies are being called on to do more.
Believing that it can continue to benefit society by responding to social demands, such as by incorporating ethical and environmental considerations in its corporate management, and not merely generating profits through business, the Group has identified the highest priority management issue as a materiality (important issues) that it needs to address. Moreover, as people engaged in the activities of a pharmaceutical company, all of our officers and employees must have a strong sense of mission and a high level of ethical standards and conduct our business activities with fairness and integrity. Through its CSR activities, the Group will contribute to extending the healthy life expectancy of people and achieving a sustainable society.
Mitsubishi Tanabe Pharma is a member of the Mitsubishi Chemical Holdings Corporation (MCHC) Group, which is working to realize KAITEKI by providing solutions to environmental and social issues and contributing to the sustainable development of society and the planet.
KAITEKI means "the sustainable well-being of people, society and our planet Earth." The MCHC Group defines "KAITEKI management" as the integrated implementation of three types of management (1) management which focuses on capital efficiency, (2) management which strives to create innovation for society, and (3) management aiming to improve sustainability while maintaining a focus on time and opportunity. The MCHC Group calls the value created from the three kinds of management "KAITEKI value." All of the MCHC Group's activities target enhancement of KAITEKI value. We believe that enhancing KAITEKI Value will lead to the realization of KAITEKI. We promote this management approach aiming to generate revenue and develop ourselves sustainably while contributing to solving environmental and social issues as a company.
For further information about KAITEKI, please see the MCHC website.
Utilization of ISO 26000
Mitsubishi Tanabe Pharma implements CSR activities for a wide range of stakeholders, including patients, healthcare professionals, local communities, and employees. In conducting these activities, we actively utilize the ISO 26000 core subject framework as we identify issues and formulate action plans. This website also introduces specific initiatives in line with the ISO 26000 core subjects.
United Nations Global Compact
Since May 2006, MCHC has participated in the United Nations Global Compact, which is being advanced by the United Nations. As a member of the MCHC Group, Mitsubishi Tanabe Pharma respects the 10 principles of the United Nations Global Compact, which address human rights, labor, the environment, and anticorruption, and upholds these principles in its business activities as a responsible corporate citizen in line with its Corporate Behavior Charter.
Communicating with Principal Stakeholders
Patients and Their Families
On its website, the Company provides a variety of disease-related information for patients and their families so that they can acquire accurate knowledge that is useful in disease prevention and treatment.
We have established the Medical Information Center to handle inquiries about the Company's products. In addition, Group company Mitsubishi Tanabe Pharma America, Inc., provides information to ALS patients in the U.S. through Searchlight Support.
As a CSR activity, we established the Mitsubishi Tanabe Pharma Tenohira Partner Program, which provides aid for the activities of associations and support groups for patients with intractable diseases. These organizations work to improve patients' medical treatment, education, career prospects, etc., and to enhance their quality of life.
We are actively providing pharmaceutical information through MRs (medical representatives). In addition, we have established information sites for healthcare professionals. In these ways, we are providing information regarding appropriate usage of ethical drugs. Furthermore, we provide information through the Community Pharmacist Support Net (CPS-net) for pharmacists and registered sales representatives who sell OTC products.
Mitsubishi Tanabe Pharma is working to further enhance its competitiveness and achieve sustained growth by focusing on its people as a management resource and giving individual employees the opportunity to demonstrate their full potential. To that end, we have established the Comprehensive Management System for Human Resources, career interviews, and a complete training system. In addition, we are taking steps to enhance mutual understanding and communication between the Company and employees, such as holding labor consultations, operating internal and external hotlines, and implementing an employee survey. Moreover, we are providing corporate information to employees by utilizing an in-house magazine and the Company intranet.
The Group has formulated its Corporate Citizenship Policy. Through educational activities at schools, company tours, local events, and the Mitsubishi Tanabe Historical Museum, we are fostering a better understanding of the Company, deepening communication with people in the areas where we conduct business, and striving to coexist in harmony with local communities.